N-cadherin in pCCL-c-MNDU3c-PGK-EGFP Citations (4)

Originally described in: Increased resistance to a farnesyltransferase inhibitor by N-cadherin expression in Bcr/Abl-P190 lymphoblastic leukemia cells.
Zhang B, Groffen J, Heisterkamp N Leukemia. 2007 Jun;21(6):1189-97. Epub 2007 Mar 29. PubMed Journal

---

Articles Citing N-cadherin in pCCL-c-MNDU3c-PGK-EGFP

Articles
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion. Hsu CC, Huang SF, Wang JS, Chu WK, Nien JE, Chen WS, Chow SE. BMC Cancer. 2016 Oct 13;16(1):800. PubMed
Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1. Bagati A, Bianchi-Smiraglia A, Moparthy S, Kolesnikova K, Fink EE, Lipchick BC, Kolesnikova M, Jowdy P, Polechetti A, Mahpour A, Ross J, Wawrzyniak JA, Yun DH, Paragh G, Kozlova NI, Berman AE, Wang J, Liu S, Nemeth MJ, Nikiforov MA. Cell Rep. 2017 Sep 19;20(12):2820-2832. doi: 10.1016/j.celrep.2017.08.057. PubMed
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. Quintanal-Villalonga A, Ferrer I, Guruceaga E, Cirauqui C, Marrugal A, Ojeda L, Garcia S, Zugazagoitia J, Munoz-Galvan S, Lopez-Rios F, Montuenga L, Vicent S, Molina-Pinelo S, Carnero A, Paz-Ares L. EBioMedicine. 2020 Mar;53:102683. doi: 10.1016/j.ebiom.2020.102683. Epub 2020 Feb 27. PubMed
MARCH family E3 ubiquitin ligases selectively target and degrade cadherin family proteins. Seo T, Lowery AM, Xu H, Giang W, Troyanovsky SM, Vincent PA, Kowalczyk AP. bioRxiv [Preprint]. 2023 Aug 10:2023.08.10.552739. doi: 10.1101/2023.08.10.552739. PubMed

If you have published an article using this material, please email us at to have your article added to this page.